Virax Biolabs Group Limited (VRAX) Stock Price History
Historical prices from 2022 to 2026
Loading 10-year price history...
Historical Performance
Short-Term Returns
VRAX Stock Price Trajectory (2022–2026)
As of March 5, 2026, Virax Biolabs Group Limited (VRAX) trades at $0.21, representing a -84.6% return over the past year. The stock has delivered a -74.2% return over five years, reflecting challenging market conditions.
The stock reached its all-time high of $290.00 on July 29, 2022. From this peak, VRAX has corrected -99.9%, currently trading 65% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers CAI (-29.1% 1Y), VCYT (+10.0% 1Y), and ADPT (+104.7% 1Y), VRAX has underperformed the peer group average. Compare VRAX vs CAI →
Historical Price Data
Showing 30 of 909 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-03-04 | 0.21 | 0.22 | 0.20 | 0.21 | 147K | +2.96% |
| 2026-03-03 | 0.22 | 0.22 | 0.19 | 0.20 | 398K | -7.85% |
| 2026-03-02 | 0.22 | 0.23 | 0.21 | 0.22 | 210K | -3.25% |
| 2026-02-27 | 0.22 | 0.23 | 0.22 | 0.23 | 78K | +3.03% |
| 2026-02-26 | 0.24 | 0.24 | 0.22 | 0.22 | 232K | -8.68% |
| 2026-02-25 | 0.22 | 0.25 | 0.22 | 0.24 | 409K | +13.24% |
| 2026-02-24 | 0.21 | 0.23 | 0.21 | 0.21 | 145K | +3.64% |
| 2026-02-23 | 0.22 | 0.22 | 0.20 | 0.21 | 167K | -3.19% |
| 2026-02-20 | 0.22 | 0.22 | 0.21 | 0.21 | 0 | -5.33% |
| 2026-02-19 | 0.22 | 0.25 | 0.22 | 0.23 | 350K | +3.21% |
| 2026-02-18 | 0.20 | 0.23 | 0.20 | 0.22 | 683K | +8.78% |
| 2026-02-17 | 0.20 | 0.22 | 0.20 | 0.20 | 25K | -3.19% |
| 2026-02-13 | 0.20 | 0.22 | 0.20 | 0.21 | 148K | -0.96% |
| 2026-02-12 | 0.22 | 0.23 | 0.20 | 0.21 | 175K | -3.69% |
| 2026-02-11 | 0.23 | 0.24 | 0.22 | 0.22 | 207K | -6.47% |
| 2026-02-10 | 0.23 | 0.26 | 0.23 | 0.23 | 183K | +0.87% |
| 2026-02-09 | 0.23 | 0.24 | 0.23 | 0.23 | 78K | +1.32% |
| 2026-02-06 | 0.23 | 0.25 | 0.22 | 0.23 | 182K | +2.25% |
| 2026-02-05 | 0.24 | 0.24 | 0.22 | 0.22 | 169K | -10.48% |
| 2026-02-04 | 0.28 | 0.28 | 0.24 | 0.25 | 158K | -7.12% |
| 2026-02-03 | 0.28 | 0.28 | 0.27 | 0.27 | 122K | -1.84% |
| 2026-02-02 | 0.27 | 0.28 | 0.26 | 0.27 | 121K | -3.89% |
| 2026-01-30 | 0.28 | 0.28 | 0.27 | 0.28 | 138K | -0.70% |
| 2026-01-29 | 0.29 | 0.29 | 0.27 | 0.28 | 194K | -1.72% |
| 2026-01-28 | 0.28 | 0.29 | 0.28 | 0.29 | 117K | +3.57% |
| 2026-01-27 | 0.29 | 0.29 | 0.27 | 0.28 | 136K | +1.08% |
| 2026-01-26 | 0.28 | 0.28 | 0.27 | 0.28 | 239K | +5.20% |
| 2026-01-24 | 0.28 | 0.28 | 0.26 | 0.26 | 124K | +0.11% |
| 2026-01-23 | 0.28 | 0.28 | 0.26 | 0.26 | 126K | -3.31% |
| 2026-01-22 | 0.28 | 0.29 | 0.27 | 0.27 | 163K | -0.37% |
See VRAX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs VRAX Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare VRAX vs LLY
See how VRAX stacks up against sector leader Eli Lilly and Company.
Start ComparisonFrequently Asked Questions
How has VRAX stock performed recently?
VRAX declined -84.6% over the past year, below its 5-year annualized CAGR of -74.2%. The stock trades below its 200-day moving average, reflecting the downtrend.
What is VRAX's all-time high price?
Virax Biolabs Group Limited reached $290.00 on 2022-07-29. The 52-week high is $1.58. Current 1-year return of -84.6% places the stock further from historical peaks.
Where can I download VRAX historical price data?
This page provides VRAX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2022-2026, downloadable in CSV format.